Although many of those factors were either borderline significant or significant on univariate analysis for predictors of new metastatic site failure (Supplementary Table 5), many lost significance after the inclusion of the extent of systemic therapy in the multivariate model.
← all excerpts
Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma.
1
—
—